These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 11437321)
21. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues. Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120 [TBL] [Abstract][Full Text] [Related]
22. Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutants. Samuele A; Facchini M; Rotili D; Mai A; Artico M; Armand-Ugón M; Esté JA; Maga G ChemMedChem; 2008 Sep; 3(9):1412-8. PubMed ID: 18465760 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors. Li W; Huang B; Kang D; De Clercq E; Daelemans D; Pannecouque C; Zhan P; Liu X Chem Biol Drug Des; 2016 Sep; 88(3):380-5. PubMed ID: 27062197 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors. Tramontano E; Marongiu ME; de Montis A; Loi AG; Artico M; Massa S; Mai A; la Colla P New Microbiol; 1994 Oct; 17(4):269-79. PubMed ID: 7532270 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Yu M; Liu X; Li Z; Liu S; Pannecouque C; Clercq ED Bioorg Med Chem; 2009 Nov; 17(22):7749-54. PubMed ID: 19819705 [TBL] [Abstract][Full Text] [Related]
26. Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors. Wang Z; Wang M; Yao X; Li Y; Qiao W; Geng Y; Liu Y; Wang Q Eur J Med Chem; 2012 Apr; 50():361-9. PubMed ID: 22369862 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 Inhibitors. Fang Z; Kang D; Zhang L; Huang B; Liu H; Pannecouque C; De Clercq E; Zhan P; Liu X Chem Biol Drug Des; 2015 Oct; 86(4):614-8. PubMed ID: 25626467 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 2-thioxopyrimidin-4(1H)-one derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors. Khalifa NM; Al-Omar MA Int J Mol Sci; 2014 Nov; 15(11):20723-35. PubMed ID: 25397597 [TBL] [Abstract][Full Text] [Related]
32. Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants. Mugnaini C; Alongi M; Togninelli A; Gevariya H; Brizzi A; Manetti F; Bernardini C; Angeli L; Tafi A; Bellucci L; Corelli F; Massa S; Maga G; Samuele A; Facchini M; Clotet-Codina I; Armand-Ugón M; Esté JA; Botta M J Med Chem; 2007 Dec; 50(26):6580-95. PubMed ID: 18052319 [TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of a new series of cyclopropylamino-linking diarylpyrimidines as HIV non-nucleoside reverse transcriptase inhibitors. Liu Y; Meng G; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J Eur J Pharm Sci; 2014 Oct; 62():334-41. PubMed ID: 24956462 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs. Li YM; Luo RH; Yang LM; Huang SM; Li SY; Zheng YG; Ni DX; Cui YM; Zhang XJ; Li XL; Zhang RH; Tang E; Zhang HB; Zheng YT; He YP; Xiao WL Bioorg Chem; 2020 Sep; 102():104041. PubMed ID: 32683184 [TBL] [Abstract][Full Text] [Related]
37. A versatile route to C-6 arylmethyl-functionalized S-DABO and related analogues. Radi M; Contemori L; Castagnolo D; Spinosa R; Esté JA; Massa S; Botta M Org Lett; 2007 Aug; 9(16):3157-60. PubMed ID: 17625879 [TBL] [Abstract][Full Text] [Related]
38. Chiral resolution and molecular modeling investigation of rac-2-cyclopentylthio-6-[1-(2,6-difluorophenyl)ethyl]-3,4-dihydro-5-methylpyrimidin-4(3H)-one (MC-1047), a potent anti-HIV-1 reverse transcriptase agent of the DABO class. Quaglia M; Mai A; Sbardella G; Artico M; Ragno R; Massa S; del Piano D; Setzu G; Doratiotto S; Cotichini V Chirality; 2001 Feb; 13(2):75-80. PubMed ID: 11170249 [TBL] [Abstract][Full Text] [Related]
39. Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies. Wu HQ; Yan ZH; Chen WX; He QQ; Chen FE; De Clercq E; Balzarini J; Daelemans D; Pannecouque C Bioorg Med Chem; 2013 Nov; 21(21):6477-83. PubMed ID: 24055077 [TBL] [Abstract][Full Text] [Related]